BACKGROUND: Adult film production is a legal, multibillion dollar industry in California. In response to reports of human immunodeficiency virus (HIV) transmission by an adult film worker, we sought to determine the extent of HIV infection among exposed workers and to identify means of improving worker safety. METHODS: The Los Angeles County Department of Health Services initiated an outbreak investigation that included interviews of infected workers to elicit information about recent sex partners, review of the testing agency's medical records and laboratory results, molecular analysis of HIV isolates from the 4 infected workers, and a risk assessment of HIV transmission in the adult film industry. RESULTS: Many adult film workers participate in a monthly program of screening for HIV infection by means of polymerase chain reaction-based technology to detect HIV DNA in blood. A male performer tested negative for HIV on 12 February 2004 and 17 March 2004, then tested positive for HIV on 9 April 2004. During the period between the negative test results, he experienced a flulike illness after performing unprotected vaginal and anal intercourse for an adult film produced outside the United States by a US company. After returning to California, he performed unprotected sex acts for adult films with 13 female partners who had all tested negative for HIV in the preceding 30 days; 3 subsequently tested positive for HIV (a 23% attack rate). Contact tracing identified no reasonable sources of infection other than the male index patient. CONCLUSION: Although current testing methods may shorten the window period to diagnosis of new HIV infection, they fail to prevent occupational acquisition of HIV in this setting. A California Occupational Safety and Health Administration-approved written health and safety program that emphasizes primary prevention is needed for this industry.
BACKGROUND: Adult film production is a legal, multibillion dollar industry in California. In response to reports of human immunodeficiency virus (HIV) transmission by an adult film worker, we sought to determine the extent of HIV infection among exposed workers and to identify means of improving worker safety. METHODS: The Los Angeles County Department of Health Services initiated an outbreak investigation that included interviews of infected workers to elicit information about recent sex partners, review of the testing agency's medical records and laboratory results, molecular analysis of HIV isolates from the 4 infected workers, and a risk assessment of HIV transmission in the adult film industry. RESULTS: Many adult film workers participate in a monthly program of screening for HIV infection by means of polymerase chain reaction-based technology to detect HIV DNA in blood. A male performer tested negative for HIV on 12 February 2004 and 17 March 2004, then tested positive for HIV on 9 April 2004. During the period between the negative test results, he experienced a flulike illness after performing unprotected vaginal and anal intercourse for an adult film produced outside the United States by a US company. After returning to California, he performed unprotected sex acts for adult films with 13 female partners who had all tested negative for HIV in the preceding 30 days; 3 subsequently tested positive for HIV (a 23% attack rate). Contact tracing identified no reasonable sources of infection other than the male index patient. CONCLUSION: Although current testing methods may shorten the window period to diagnosis of new HIV infection, they fail to prevent occupational acquisition of HIV in this setting. A California Occupational Safety and Health Administration-approved written health and safety program that emphasizes primary prevention is needed for this industry.
Authors: Dawn K Smith; Lisa A Grohskopf; Roberta J Black; Judith D Auerbach; Fulvia Veronese; Kimberly A Struble; Laura Cheever; Michael Johnson; Lynn A Paxton; Ida M Onorato; Alan E Greenberg Journal: MMWR Recomm Rep Date: 2005-01-21
Authors: Pragna Patel; Jeffrey D Klausner; Oliver M Bacon; Sally Liska; Melanie Taylor; Anthony Gonzalez; Robert P Kohn; William Wong; Sydney Harvey; Peter R Kerndt; Scott D Holmberg Journal: J Acquir Immune Defic Syndr Date: 2006-05 Impact factor: 3.731
Authors: E S Daar; S Little; J Pitt; J Santangelo; P Ho; N Harawa; P Kerndt; J V Glorgi; J Bai; P Gaut; D D Richman; S Mandel; S Nichols Journal: Ann Intern Med Date: 2001-01-02 Impact factor: 25.391
Authors: Christopher D Pilcher; Susan A Fiscus; Trang Q Nguyen; Evelyn Foust; Leslie Wolf; Del Williams; Rhonda Ashby; Judy Owen O'Dowd; J Todd McPherson; Brandt Stalzer; Lisa Hightow; William C Miller; Joseph J Eron; Myron S Cohen; Peter A Leone Journal: N Engl J Med Date: 2005-05-05 Impact factor: 91.245
Authors: John T Brooks; Kenneth E Robbins; Ae S Youngpairoj; Harlan Rotblatt; Peter R Kerndt; Melanie M Taylor; Eric S Daar; Marcia L Kalish Journal: AIDS Date: 2006-04-04 Impact factor: 4.177
Authors: Corita R Grudzen; Marc N Elliott; Peter R Kerndt; Mark A Schuster; Robert H Brook; Lillian Gelberg Journal: Am J Public Health Date: 2009-02-12 Impact factor: 9.308
Authors: Kimberly A Powers; Azra C Ghani; William C Miller; Irving F Hoffman; Audrey E Pettifor; Gift Kamanga; Francis Ea Martinson; Myron S Cohen Journal: Lancet Date: 2011-07-16 Impact factor: 79.321
Authors: Martin Stürmer; Katrin Zimmermann; Carlos Fritzsche; Emil Reisinger; Gottfried Doelken; Annemarie Berger; Hans W Doerr; Josef Eberle; Lutz G Gürtler Journal: Med Microbiol Immunol Date: 2010-03-09 Impact factor: 3.402
Authors: Stefan David Baral; M Reuel Friedman; Scott Geibel; Kevin Rebe; Borche Bozhinov; Daouda Diouf; Keith Sabin; Claire E Holland; Roy Chan; Carlos F Cáceres Journal: Lancet Date: 2014-07-22 Impact factor: 79.321